WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
Live Science on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback